# Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

> **NCT04597099** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 10 (estimated)

## Conditions studied

- PCOS
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Micronized progesterone
- **DRUG:** Placebo
- **DRUG:** Flutamide
- **DRUG:** Estradiol patch

## Key facts

- **NCT ID:** NCT04597099
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-26
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597099, "Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04597099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*